Big Brother Winner's Wife Diagnosed With Cancer
Becca Devens, wife of Big Brother winner Rick Devens, has been diagnosed with breast cancer and will undergo a double mastectomy.
U.S. Cancer News
This section covers cancer as a medical and research subject in the United States — new treatments, clinical findings, regulatory approvals and the guidelines that shape how the disease is screened and managed. Reporting draws on the full range of cancer types and the research systems that study them.
Recent news
November 8, 2026
Jack McCaffery Takes Leave for Lymphoma TreatmentThe University of Richmond basketball player is receiving care at the Hospital of the University of Pennsylvania after a Hodgkin lymphoma diagnosis.
November 7, 2026
Cancer Survivors Still Drink at Steady RatesA study of nearly 4 million U.S. adults finds drinking among cancer survivors held at 45.8% between 2016 and 2024.
November 7, 2026
Study Finds Delays in Bladder Cancer ChemotherapyA retrospective Columbia University analysis found more than a third of muscle-invasive bladder cancer patients waited over 60 days to start neoadjuvant chemotherapy.
November 7, 2026
IMGT Starts Confirmatory Pancreatic Cancer TrialThe U.S. study tests whether focused ultrasound combined with chemotherapy improves survival for patients with borderline resectable and locally advanced pancreatic cancer.
November 7, 2026
FDA Approves Rasonque for Pancreatic CancerThe first RAS inhibitor cleared for pancreatic cancer targets a gene family driving most cases of the disease.
November 7, 2026
BeOne Raises 2026 Revenue Outlook to $7 BillionThe biotech company lifted its full-year revenue projection after third-quarter sales rose 34% to $1.4 billion.
November 6, 2026
Low-Risk Prostate Cancer Share Falls SharplyA study of U.S. patient records finds fewer localized prostate cancers are classified as low-risk, and more low-risk patients are receiving no active treatment.
November 6, 2026
Phio Presents PH-762 Phase 1b Data at SITCPhio Pharmaceuticals will share Phase 1b clinical results for its INTASYL PH-762 treatment at the 41st SITC Annual Meeting in Phoenix, Arizona.
November 6, 2026
MDA Seeks Information on Zolgensma Tumor ReportsThe Muscular Dystrophy Association is reviewing safety data after Novartis reported tumor cases in patients treated with the spinal muscular atrophy gene therapy.
November 6, 2026
FDA Approves Alembic's Generic Venetoclax TabletsThe generic version of AbbVie's Venclexta is rated therapeutically equivalent, though launch timing and price remain unannounced.
More in Cancer
Coverage here tracks clinical trial results, drug and therapy approvals, screening guideline updates, study findings on environmental and genetic risk factors, and the research funding and institutional decisions that shape what gets studied. New York, Los Angeles, Chicago, Houston and Phoenix are home to major cancer research and treatment centers whose announcements and publications regularly generate national coverage. Approval timelines for new therapies can extend for years from first clinical evidence to regulatory decision, and that arc produces a running set of stories that build on each other. Screening guidelines generate recurring coverage because changes to recommended intervals or populations reach the largest number of people of any single development in this subject area.